Compartment-specific immune and tumor markers associated with clinical outcomes in patients with and without sarcomatoid/rhabdoid renal cell carcinoma treated with ipilimumab and nivolumab
ESMO Open · 2026-05 · 11 (5) · 106908
DOI: 10.1016/j.esmoop.2026.106908 ↗Kurz gefasst
Fachartikel in der Zeitschrift ESMO Open, 2026-05. Verfasst von N Savion-Gaiger und 9 weiteren Autor:innen. Beteiligte Einrichtung: Yale Cancer Center, Yale School of Medicine, New Haven, USA. Hauptthemen laut MEDLINE: Carcinoma, Renal Cell, Biomarkers, Tumor, Kidney Neoplasms, Ipilimumab. Die Arbeit nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Yale University, US Department of Defense, NIH.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Yale Cancer Center, Yale School of Medicine, New Haven, USA.
- Yale Cancer Center, Yale School of Medicine, New Haven, USA; Department of Surgery, Yale New Haven Hospital, New Haven, USA.
- Department of Pathology, Yale School of Medicine, New Haven, USA.
- Yale Cancer Center, Yale School of Medicine, New Haven, USA; Department of Medicine (Medical Oncology), Yale University School of Medicine, New Haven, USA. Electronic address: harriet.kluger@yale.edu.
- Yale Cancer Center, Yale School of Medicine, New Haven, USA; Department of Medicine (Medical Oncology), Yale University School of Medicine, New Haven, USA. Electronic address: david.schoenfeld@yale.edu.
Förderung
- Yale University
- US Department of Defense
- NIH
Zitieren
APA
Savion-Gaiger, N., Perales, O., Su, D. G., Bar-Ziv, D., Challa, P., Djureinovic, D., Yi, I., Adeniran, A., Kluger, H., & Schoenfeld, D. (2026). Compartment-specific immune and tumor markers associated with clinical outcomes in patients with and without sarcomatoid/rhabdoid renal cell carcinoma treated with ipilimumab and nivolumab. ESMO Open, 11(5), 106908. https://doi.org/10.1016/j.esmoop.2026.106908
Vancouver
Savion-Gaiger N, Perales O, Su DG, Bar-Ziv D, Challa P, Djureinovic D, et al. Compartment-specific immune and tumor markers associated with clinical outcomes in patients with and without sarcomatoid/rhabdoid renal cell carcinoma treated with ipilimumab and nivolumab. ESMO Open. 2026;11(5):106908. doi:10.1016/j.esmoop.2026.106908
BibTeX
@article{SavionGaiger2026,
author = {Savion-Gaiger, N and Perales, O and Su, D G and Bar-Ziv, D and Challa, P and Djureinovic, D and Yi, I and Adeniran, A and Kluger, H and Schoenfeld, D},
title = {Compartment-specific immune and tumor markers associated with clinical outcomes in patients with and without sarcomatoid/rhabdoid renal cell carcinoma treated with ipilimumab and nivolumab},
journal = {ESMO Open},
year = {2026},
volume = {11},
number = {5},
pages = {106908},
doi = {10.1016/j.esmoop.2026.106908}
}
EUVIMED